Med Page Today
NOVEMBER 26, 2024
(MedPage Today) -- Nearly half of participants in a weight-loss program who consumed alcohol at baseline began drinking less after adding an obesity drug into their weight-management regimen, a cohort study indicated. Among the 7,491 participants.
Science Daily - Heart Disease
NOVEMBER 26, 2024
A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world's most common heart valve disease -- aortic stenosis (AS).
HCPLive
NOVEMBER 26, 2024
The investigators of this study noted an association between obesity and conditions such as rosacea, psoriasis, and lichen simplex chronicus.
Med Page Today
NOVEMBER 26, 2024
(MedPage Today) -- Men at high risk of cardiovascular disease had brain volume changes a decade earlier than women, U.K. Biobank data showed. Cardiovascular risk and obesity had the strongest relationship with lower gray matter volume in men between.
JAMA Cardiology
NOVEMBER 26, 2024
This study compares clopidogrel vs aspirin monotherapy in patients with high bleeding risk and/or percutaneous coronary intervention complexity.
HCPLive
NOVEMBER 26, 2024
The FDA set the Prescription Drug User Fee Act (PDUFA) date for the investigational RNAi therapeutic as March 23, 2025.
Science Daily - Heart Disease
NOVEMBER 26, 2024
You may have heard sleep described as something of a magic pill for the body. With the right amount, timing, and quality, it can work wonders -- strengthen the immune system, improve blood sugar, even decrease the risk of heart attacks and strokes. Sleep differences have been reported for some time in men and women, but it is not well known whether the characteristics of sleep serve different functions in one gender over the other, especially as it relates to the heart.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Medical Xpress - Cardiology
NOVEMBER 26, 2024
You may have heard sleep described as something of a magic pill for the body. With the right amount, timing, and quality, it can work wonders—strengthen the immune system, improve blood sugar, even decrease the risk of heart attacks and strokes. Sleep differences have been reported for some time in men and women, but it is not well known whether the characteristics of sleep serve different functions in one gender over the other, especially as it relates to the heart.
Becker's Hospital Review - Cardiology
NOVEMBER 26, 2024
An Atlanta-based Emory University Hospital team became the first in the U.S. to perform a surgical implantation of magnetically levitated ventricular assist device.
Med Page Today
NOVEMBER 26, 2024
(MedPage Today) -- The American Heart Association said that hunters should be advised that physical exertion, colder temperatures, and the thrill of the hunt can put them at risk for heart attack or stroke. Merck announced positive topline results.
Medical Xpress - Cardiology
NOVEMBER 26, 2024
Human skin cells have been reprogrammed into heart valve cells and then used to successfully transplant a pig heart valve into a rodent, led by the research of a Northeastern University professor.
Science Daily - Stroke
NOVEMBER 26, 2024
Healing the gut may be the key to improving long-term recovery in stroke patients, scientists have found. The latest of multiple studies highlights the potential of this novel avenue of treatment, which takes advantage of the link between the brain and digestive system to curb cognitive impairment and other lingering impacts of a stroke or brain trauma.
HeartRhythm
NOVEMBER 26, 2024
Mavacamten is a selective, allosteric, and reversible cardiac myosin inhibitor, representing the first disease-specific treatment for obstructive hypertrophic cardiomyopathy (HCM) that targets the core pathophysiological mechanism of this condition. Clinical evidence supports its efficacy in improving symptoms, cardiac function and remodeling, thereby supplementing established treatment regimes.
American College of Cardiology
NOVEMBER 26, 2024
The following are key points to remember from a 2024 updated international consensus statement on platelet function and genetic testing in percutaneous coronary intervention (PCI).
European Journal of Heart Failure
NOVEMBER 26, 2024
Discontinuation and reinitiation of mineralocorticoid receptor antagonists (MRA) in patients with heart failure and reduced ejection fraction (HFrEF). BMI, body mass index; eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association. Abstract Aims Mineralocorticoid receptor antagonists (MRA) improve outcomes in heart failure with reduced ejection fraction (HFrEF) but are underused.
Frontiers in Cardiovascular Medicine
NOVEMBER 26, 2024
Cardiovascular disease (CVD) is responsible for approximately 30% of annual global mortality rates, yet existing treatments for this condition are considered less than ideal. Despite being previously overlooked, lactate, a byproduct of glycolysis, is now acknowledged for its crucial role in the cellular functions of the cardiovascular system. Recent studies have shown that lactate influences the proliferation, differentiation, and activation of immune cells through its modulation of post-transla
Science Daily - Heart Disease
NOVEMBER 26, 2024
Routine screening to detect risk factors for heart disease dropped sharply during the COVID-19 pandemic in England, and some key measurements, such as blood pressure readings, may still lag behind pre-pandemic levels, according to a new study.
American College of Cardiology
NOVEMBER 26, 2024
What are the outcomes of patients referred for ventricular tachycardia (VT) ablation according to left ventricular ejection fraction (LVEF), tolerance of VT, and acute ablation outcome?
HCPLive
NOVEMBER 26, 2024
A study demonstrates many people with treatment-resistant schizophrenia do not comply with nutritional recommendations, which can contribute to increased mortality risk.
American College of Cardiology
NOVEMBER 26, 2024
Individuals with type 2 diabetes (T2D) experienced two-fold more cardiovascular disease events than matched comparisons in the general population as much as 30 years before their diagnosis of T2D, according to results from a large, contemporary, nationwide registry-based study published Nov. 25 in JACC.
HCPLive
NOVEMBER 26, 2024
Amgen’s MariTide achieved up to 20% average weight loss at 52 weeks without hitting a plateau in individuals with obesity or overweight.
Society of Thoracic Surgeons - Allied Health
NOVEMBER 26, 2024
Event STS 2025 Coding Workshop gmckinney Tue, 11/26/2024 - 10:25 Event dates Feb 28 – Mar 1, 2025 Location Virtual Register Now Early Bird registration deadline: Jan. 17 Description The STS 2025 Coding Workshop: Best Practices for Cardiothoracic Surgery is a 2-day virtual event that provides coders, surgeons, and billing professionals with the latest updates to CPT and physician coding and reimbursement.
HCPLive
NOVEMBER 26, 2024
In this segment of the latest Lungcast episode, the characteristics of AERD and the concerns of patients were highlighted.
Medical Xpress - Cardiology
NOVEMBER 26, 2024
From 2021 to 2023, there was an increase in prescription rates of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) for patients with heart failure and a left ventricular ejection fraction (LVEF) greater than 40 percent, according to a study published online Nov. 18 in JAMA Cardiology to coincide with the American Heart Association Scientific Sessions 2024, held from Nov. 16 to 18 in Chicago.
HCPLive
NOVEMBER 26, 2024
Hirschfield describes the need for therapies that address itch in PBC and explains what linerixibat, an IBAT inhibitor, may offer for pruritus.
Cardiovascular Diabetology
NOVEMBER 26, 2024
Globally, cardiovascular disease (CVD) constitutes the primary cause of death, with insulin resistance (IR), measured by the triglyceride-glucose (TyG) index, and visceral obesity, reflected by the Chinese Vis.
Journal of Cardiothoracic Surgery
NOVEMBER 26, 2024
With the continuous development of minimally invasive thoracic surgery, thoracoscopic thymectomy has become a routine operation. This method, now widely recognized, better protects lung function, reduces intra.
HCPLive
NOVEMBER 26, 2024
Patients in the anifrolumab arm also had lower rates of damage accrual.
Becker's Hospital Review - Cardiology
NOVEMBER 26, 2024
GLP-1 medications reduced the risk of major adverse cardiovascular events by 13% compared to a placebo, according to a study published Nov. 25 in The Lancet Diabetes & Endocrinology.
HCPLive
NOVEMBER 26, 2024
Strnad reviews findings from a proteomic analysis about AATD-associated liver disease and how they may aid future disease monitoring and drug development.
American College of Cardiology
NOVEMBER 26, 2024
Use of intravascular lithotripsy (IVL) for the treatment of in-stent restenosis (ISR), although off-label, may be safe and feasible, according to a study reviewing data from the ACC's CathPCI Registry published in JACC: Cardiovascular Interventions.
HCPLive
NOVEMBER 26, 2024
Conaghan discussed findings from a phase 2 trial at the ACR 2024 Convergence.
American College of Cardiology
NOVEMBER 26, 2024
In this interview, Thomas H. Marwick, MD, PhD, FACC, and Alison L. Bailey, MD FACC, discuss the Top Takeaways from 2024 in Cardiovascular (CV) Imaging. Dr. Marwick discusses the SCOT-HEART trial, patient-echo reports augmented by AI, tricuspid valve regurgitation, and more.
HCPLive
NOVEMBER 26, 2024
Vivek Kaul, MD, discusses the benefits of using a stool DNA test for colorectal cancer screening, emphasizing its sensitivity, guideline recommendations, and its potential to reduce the screening burden for patients, as well as explaining the test's mechanism of action.
Frontiers in Cardiovascular Medicine
NOVEMBER 26, 2024
Cardio Vascular risk prevention in Germany has a gap between the ages of 20 and 30 years. We established a program for risk group identification in students and analyzed the screenings according to the ACCF/AHA Stages and NYHA functional classification. In a cross-sectional design, 596 participants completed a sports medical and motor performance check-up.
European Journal of Heart Failure
NOVEMBER 26, 2024
( A ) The cumulative incidence rate for cardiovascular death (CVD) was higher in the same control patients when analysed using baseline inflammatory plasma biomarkers high-sensitivity C-reactive protein (hsCRP) 2mg/L ( left panel ) and interleukin (IL)-6 3.4pg/ml ( right panel ). The effect of mesenchymal precursor cells (MPCs) on ( B ) 2-point major adverse cardiovascular events (MACE) (myocardial infarction [MI] or stroke) and ( C ) 3-point MACE (MI or stroke or CVD) in all patients with hear
Medical Xpress - Cardiology
NOVEMBER 26, 2024
New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small hole in the heart) in patients with atrial fibrillation (AF) undergoing pulmonary vein isolation (PVI) in a single procedure.
Expert insights. Personalized for you.
118 
Let's personalize your content